JANX Q2 2021 Earnings — Janux Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

JANXJanux Therapeutics, Inc.

$852M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$482,000

Gross Profit

-$4M-882.8% margin

Operating Income

-$6M-1297.1% margin

Net Income

-$6M-1287.6% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

+26.8%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$397M

Total Liabilities

$12M

Stockholders' Equity

$385M

Cash & Equivalents

$252M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$482,000	$0	—
Gross Profit	-$4M	$0	—
Operating Income	-$6M	-$1M	-465.3%
Net Income	-$6M	-$2M	-152.3%